• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,186.87 0.00
( 0.00%)
Global Indices
Nasdaq
52,569.33 -110.31
(-0.21%)
Dow Jones
7,555.54 -37.86
(-0.50%)
Hang Seng
66,873.37 -1,878.14
(-2.73%)
Nikkei 225
10,555.24 39.32
(0.37%)
Forex
USD-INR
96.14 0.39
(0.40%)
EUR-INR
109.70 0.52
(0.48%)
GBP-INR
128.61 0.54
(0.42%)
JPY-INR
0.59 0.00
(0.41%)

EQUITY - MARKET SCREENER

Tourism Finance Corporation of India Ltd
Industry :  Finance - Term-Lending Institutions
BSE Code
ISIN Demat
Book Value()
526650
INE305A01023
28.4060497
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TFCILTD
31.37
3877.9
EPS(TTM)
Face Value()
Div & Yield %
2.67
2
0.72
 

Sandu Pharmaceuticals standalone net profit rises 75.00% in the December 2025 quarter
Feb 07,2026
Net profit of Sandu Pharmaceuticals rose 75.00% to Rs 0.98 crore in the quarter ended December 2025 as against Rs 0.56 crore during the previous quarter ended December 2024. Sales rose 2.12% to Rs 18.76 crore in the quarter ended December 2025 as against Rs 18.37 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales18.7618.37 2
OPM %5.605.44 -
PBDT1.030.99 4
PBT0.860.80 8
NP0.980.56 75